<ol class="cite-this-references"><li id="reference-A1440">Macdonald S: Aspirin use to be banned in under 16 year olds. BMJ. 2002 Nov 2;325(7371):988. [<a href="/articles/A1440" target="_blank">Article</a>] </li><li id="reference-A1441">Sneader W: The discovery of aspirin: a reappraisal. BMJ. 2000 Dec 23-30;321(7276):1591-4. [<a href="/articles/A1441" target="_blank">Article</a>] </li><li id="reference-A1442">Aukerman G, Knutson D, Miser WF: Management of the acute migraine headache. Am Fam Physician. 2002 Dec 1;66(11):2123-30. [<a href="/articles/A1442" target="_blank">Article</a>] </li><li id="reference-A1443">Authors unspecified: Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Lancet. 1988 Aug 13;2(8607):349-60. [<a href="/articles/A1443" target="_blank">Article</a>] </li><li id="reference-A1444">Dorsch MP, Lee JS, Lynch DR, Dunn SP, Rodgers JE, Schwartz T, Colby E, Montague D, Smyth SS: Aspirin resistance in patients with stable coronary artery disease with and without a history of myocardial infarction. Ann Pharmacother. 2007 May;41(5):737-41. Epub 2007 Apr 24. [<a href="/articles/A1444" target="_blank">Article</a>] </li><li id="reference-A177217">Levy G: Clinical pharmacokinetics of aspirin. Pediatrics. 1978 Nov;62(5 Pt 2 Suppl):867-72. [<a href="/articles/A177217" target="_blank">Article</a>] </li><li id="reference-A35408">Authors unspecified: Guidance document: management priorities in salicylate toxicity. J Med Toxicol. 2015 Mar;11(1):149-52. doi: 10.1007/s13181-013-0362-3. [<a href="/articles/A35408" target="_blank">Article</a>] </li><li id="reference-A32954">Durnas C, Cusack BJ: Salicylate intoxication in the elderly. Recognition and recommendations on how to prevent it. Drugs Aging. 1992 Jan-Feb;2(1):20-34. [<a href="/articles/A32954" target="_blank">Article</a>] </li><li id="reference-A177241">Flower R: What are all the things that aspirin does? BMJ. 2003 Sep 13;327(7415):572-3. doi: 10.1136/bmj.327.7415.572. [<a href="/articles/A177241" target="_blank">Article</a>] </li><li id="reference-A10989">Hall MN, Campos H, Li H, Sesso HD, Stampfer MJ, Willett WC, Ma J: Blood levels of long-chain polyunsaturated fatty acids, aspirin, and the risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2007 Feb;16(2):314-21. [<a href="/articles/A10989" target="_blank">Article</a>] </li><li id="reference-A32682">Vane JR, Botting RM: The mechanism of action of aspirin. Thromb Res. 2003 Jun 15;110(5-6):255-8. [<a href="/articles/A32682" target="_blank">Article</a>] </li><li id="reference-A177256">Vane JR, Bakhle YS, Botting RM: Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol. 1998;38:97-120. doi: 10.1146/annurev.pharmtox.38.1.97. [<a href="/articles/A177256" target="_blank">Article</a>] </li><li id="reference-A177265">Varga Z, Sabzwari SRA, Vargova V: Cardiovascular Risk of Nonsteroidal Anti-Inflammatory Drugs: An Under-Recognized Public Health Issue. Cureus. 2017 Apr 8;9(4):e1144. doi: 10.7759/cureus.1144. [<a href="/articles/A177265" target="_blank">Article</a>] </li><li id="reference-A177268">Ornelas A, Zacharias-Millward N, Menter DG, Davis JS, Lichtenberger L, Hawke D, Hawk E, Vilar E, Bhattacharya P, Millward S: Beyond COX-1: the effects of aspirin on platelet biology and potential mechanisms of chemoprevention. Cancer Metastasis Rev. 2017 Jun;36(2):289-303. doi: 10.1007/s10555-017-9675-z. [<a href="/articles/A177268" target="_blank">Article</a>] </li><li id="reference-A177325">Alfonso L, Ai G, Spitale RC, Bhat GJ: Molecular targets of aspirin and cancer prevention. Br J Cancer. 2014 Jul 8;111(1):61-7. doi: 10.1038/bjc.2014.271. Epub 2014 May 29. [<a href="/articles/A177325" target="_blank">Article</a>] </li><li id="reference-A177400">Tsoi KKF, Ho JMW, Chan FCH, Sung JJY: Long-term use of low-dose aspirin for cancer prevention: A 10-year population cohort study in Hong Kong. Int J Cancer. 2018 Dec 21. doi: 10.1002/ijc.32083. [<a href="/articles/A177400" target="_blank">Article</a>] </li><li id="reference-A177403">Li D, Wang P, Yu Y, Huang B, Zhang X, Xu C, Zhao X, Yin Z, He Z, Jin M, Liu C: Tumor-preventing activity of aspirin in multiple cancers based on bioinformatic analyses. PeerJ. 2018 Sep 26;6:e5667. doi: 10.7717/peerj.5667. eCollection 2018. [<a href="/articles/A177403" target="_blank">Article</a>] </li><li id="reference-T562">Hasan Arif; Sandeep Aggarwal (2018). Salicylic Acid (Aspirin): StatPearls. StatPearls Publishing. </li><li id="reference-L5968">Mayo Clinic website: Salicylate [<a href="https://www.mayoclinic.org/drugs-supplements/salicylate-oral-route-rectal-route/proper-use/drg-20070551" target="_blank">Link</a>] </li><li id="reference-L12282">Health Canada Product Monograph: Aspirin (acetylsalicylic acid) for oral administration [<a href="https://pdf.hres.ca/dpd_pm/00000653.PDF" target="_blank">Link</a>] </li><li id="reference-F4405">Durlaza FDA label [<a href="//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/405/original/Durlaza_%28Extended_Release%29.pdf?1555433930" target="_blank">File</a>] </li></ol>